Patrick J. McEnany, President and CEO at CATALYST PHARMACEUTICALS, INC. (CPRX), sold 273,556 shares at $5.52 ($1.5M) on 2021-08-20, disclosed to the SEC on 2021-08-24.
Open-market sale of $1.5M CPRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.52 | 54,161 | $299K | 19.6% |
| 2 | $5.52 | 54,161 | $299K | 19.6% |
| 3 | $5.63 | 82,617 | $465K | 30.4% |
| 4 | $5.63 | 82,617 | $465K | 30.4% |
| Total | $5.59 avg | 273,556 | $1.5M | 100% |
| Filing → |
| CPRX | SELL | 2024-11-15 | $4.1M | — | Filing → |
| CPRX | SELL | 2024-11-13 | $13.1M | — | Filing → |
| CPRX | SELL | 2023-05-17 | $692K | — | Filing → |